[ Price : $8.95]
FDA accepts for priority review a Daiichi Sankyo and Merck BLA for ifinatamab deruxtecan, an investigational therapy for patients ...[ Price : $8.95]
FDA cites Pfizer over social media promotions for its cancer drug Adcetris, stating that certain Facebook advertisements are false...[ Price : $8.95]
A new policy analysis from the Cato Institute urges FDA to modernize its regulatory framework for artificial intelligence in healt...[ Price : $8.95]
FDA accepts a Telix Pharmaceuticals resubmitted NDA for TLX101-Px, an investigational PET imaging agent for glioma.[ Price : $8.95]
FDA cites significant manufacturing and quality control deficiencies at an active pharmaceutical ingredient facility operated by O...[ Price : $8.95]
FDA issues Replimune another complete response letter, declining to approve its BLA for vusolimogene oderparepvec in combination w...[ Price : $8.95]
FDA issues an early alert regarding a potential safety issue affecting certain sizing catheters manufactured by Cook Medical.[ Price : $8.95]
Representative Jake Auchincloss (D-MA) urges FDA whistleblowers to come forward to disclose instances of wrongdoing by agency mana...